DOMO Film Solutions to source 100% renewable energy for nylon film production

DOMO Film Solutions has announced that it will start sourcing 100% renewable energy for the production of its nylon film from January 2020. The move reflects DOMO’s continuous commitment to providing low-carbon nylon film.

“Thanks to this reduction in carbon footprint, NYLEEN™ has made another step forward towards offering industry a sustainable nylon film solution as we continue to improve our production processes. This family of nylon films has a proven low carbon footprint and this use of renewable energy will help to lower that even further”, says Attilio Annoni, Managing Director at DOMO Film Solutions.

DOMO Film Solutions has already achieved significant improvements in its precise carbon footprint assessment. In 2018, the company accurately measured the amount of CO₂ emitted by 1 ton of its nylon film production. This assessment was implemented by DOMO’s partner Quantis which performed a detailed and complete Life Cycle Assessment. It found NYLEEN™ to have a significantly lower carbon footprint when compared to standard nylon film.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report